This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmidt, H. H.-J. Articles by Manns, M. P. Search for Related Content PubMed PubMed Citation Articles by Schmidt, H. H.-J. Articles by Manns, M. P.

Delayed Low Density Lipoprotein (LDL) Catabolism Despite a Functional Intact LDL-Apolipoprotein B Particle and LDL-Receptor in a Subject with Clinical Homozygous Familial Hypercholesterolemia

Abteilung Gastroenterologie und Hepatologie (H.H.-J.S., C.B., M.W., M.P.M.) and Abteilung Humangenetik (M.S., M.E.), Medizinische Hochschule Hannover, Hannover, Germany; Medizinische Poliklinik (C.K.S.), Ludwig-Maximilians-Universität, München Medizinische Klinik I (U.B.), Universitäts-Klinik Eppendorf, Hamburg, Germany; and Molecular Disease Branch (R.S., L.A.Z., H.B.B.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Hartmut H.-J. Schmidt, Abteilung Gastroenterologie und Hepatologie, Medizinische Hochschule Hannover, 30623 Hannover, Germany.

We identified a 38-yr-old male patient with the clinical expression of homozygous familial hypercholesterolemia presenting as severe coronary artery disease, tendon and skin xanthomas, arcus lipoides, and joint pain. The genetic trait seems to be autosomal recessive. Interestingly, serum concentrations of cholesterol responded well to diet and statins. We had no evidence of an abnormal low density lipoprotein (LDL)-apolipoprotein B (apoB) particle, which was isolated from the patient using the U937 proliferation assay as a functional test of the LDL-binding capacity. The apoB 3500 and apoB 3531 defects were ruled out by PCR. In addition, we found no evidence for a defect within the LDL-receptor by skin fibroblast analysis, linkage analysis, single-strand conformational polymorphism and Southern blot screening across the entire LDL-receptor gene. The in vivo kinetics of radioiodinated LDL-apoB were evaluated in the proband and three normal controls, subsequently. The LDL-apoB isolated from the patient showed a normal catabolism, confirming an intact LDL particle. In contrast the fractional catabolic rate (d^-1) of autologous LDL in the subject and the normal controls revealed a remarkable delayed catabolism of the patient’s LDL (0.15 vs. 0.33–0.43 d^-1). In addition, the elevation of LDL-cholesterol in the patient resulted from an increased production rate with 22.8 mg/kg per day vs. 12.7–15.7 mg/kg per day. These data indicate that there is another catabolic defect beyond the apoB and LDL-receptor gene causing familial hypercholesterolemia.

This article has been cited by other articles:

				M. Harada-Shiba, A. Takagi, K. Marutsuka, S. Moriguchi, H. Yagyu, S. Ishibashi, Y. Asada, and S. Yokoyama Disruption of Autosomal Recessive Hypercholesterolemia Gene Shows Different Phenotype In Vitro and In Vivo Circ. Res., October 29, 2004; 95(9): 945 - 952. [Abstract] [Full Text] [PDF]

				A. K. Soutar, R. P. Naoumova, and L. M. Traub Genetics, Clinical Phenotype, and Molecular Cell Biology of Autosomal Recessive Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1963 - 1970. [Abstract] [Full Text] [PDF]

				M. Harada-Shiba, A. Takagi, Y. Miyamoto, M. Tsushima, Y. Ikeda, S. Yokoyama, and A. Yamamoto Clinical Features and Genetic Analysis of Autosomal Recessive Hypercholesterolemia J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2541 - 2547. [Abstract] [Full Text] [PDF]

				C. K. Garcia, K. Wilund, M. Arca, G. Zuliani, R. Fellin, M. Maioli, S. Calandra, S. Bertolini, F. Cossu, N. Grishin, et al. Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein Science, May 18, 2001; 292(5520): 1394 - 1398. [Abstract] [Full Text]